These changes are also associated with increased Caspase 3/7 activities in NSCLC cells upon treating them with SMI or shRNA-PKM2, which is a hallmark of apoptosis suggesting that SMI or shRNA-PKM2 affected the cell viability by inducing Caspase 3/7 mediated apoptosis. This evidence concerns the gene PKM and non-small cell lung carcinoma.